APOE genotype and functional outcome following aneurysmal subarachnoid hemorrhage

Biological Research for Nursing

Volumn 10, Issue 3, 2009, Pages 205-212

  Gallek, Matthew J ^a,c   Conley, Yvette P ^a   Sherwood, Paula R ^a   Horowitz, Michael B ^b   Kassam, Amin ^b   Alexander, Sheila A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Apolipoprotein E; Cerebral vasospasm; Glasgow Outcome Score; Modified Rankin Score; Subarachnoid hemorrhage

Indexed keywords

APOLIPOPROTEIN E;

ADOLESCENT; ADULT; AGED; ARTICLE; GENETICS; GENOTYPE; HUMAN; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; SUBARACHNOID HEMORRHAGE;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS E; GENOTYPE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; SUBARACHNOID HEMORRHAGE;

EID: 57649214121     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800408323221     Document Type: Article

References (46)

1. Alberts, M.J., Graffagnino, C., McClenny, C., DeLong, D., Strittmatter, W., Saunders, A.M., et al. (1995). ApoE genotype and survival from intracerebral haemorrhage [see comment]. Lancet, 346, 575.
2. Bederson, J.B., Germano, I.M., & Guarino, L. (1995). Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke, 26, 1086-1091 ; discussion 1091-1082.
3. Blain, J.F., Sullivan, P.M., & Poirier, J. (2006). A deficit in astroglial organization causes the impaired reactive sprouting in human apolipoprotein E4 targeted replacement mice. Neurobiology of Disease, 21, 505-514.
4. Corder, E.H., Saunders, A.M., Risch, N.J., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C. Jr., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 180-184.
5. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families [see comment]. Science, 261, 921-923.
6. DeMattos, R.B., Rudel, L.L., & Williams, D.L. (2001). Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth. Journal of Lipid Research, 42, 976-987.
7. Dunn, L.T., Stewart, E., Murray, G.D., Nicoll, J.A., & Teasdale, G.M. (2001). The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: A preliminary study. Neurosurgery, 48, 1006-1010 ; discussion 1010-1001.
8. Fisher, C.M. (1975). Clinical syndromes in cerebral thrombosis, hypertensive hemorrhage, and ruptured saccular aneurysm. Clinical Neurosurgery, 22, 117-147.
9. Fleisher, A., Grundman, M., Jack, C.R., Jr., Petersen, R.C., Taylor, C., Kim, H.T., et al. (2005). Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Archives of Neurology, 62, 953-957.
10. Gennarelli, T.A., Thibault, L.E., Adams, J.H., Graham, D.I., Thompson, C.J., & Marcincin, R.P. (1982). Diffuse axonal injury and traumatic coma in the primate. Annals of Neurology, 12, 564-574.
11. Hall, K., Cope, D.N., & Rappaport, M. (1985). Glasgow Outcome Scale and Disability Rating Scale: Comparative usefulness in following recovery in traumatic head injury. Archives of Physical Medicine & Rehabilitation, 66, 35-37.
12. Hayashi, H., Campenot, R.B., Vance, D.E., & Vance, J.E. (2007). Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1. Journal of Neuroscience, 27, 1933-1941.
13. Hayashi, H., Igbavboa, U., Hamanaka, H., Kobayashi, M., Fujita, S.C., Wood, W.G., et al. (2002). Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice. Neuroreport, 13, 383-386.
14. Hixson, J.E., & Vernier, D.T. (1990). Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. Journal of Lipid Research, 31, 545-548.
15. Isoniemi, H., Tenovuo, O., Portin, R., Himanen, L., & Kairisto, V. (2006). Outcome of traumatic brain injury after three decades-relationship to ApoE genotype. Journal of Neurotrauma, 23, 1600-1608.
16. Jennett, B. (1976). Outcome after severe head injury: Definitions and predictions. Medical Journal of Australia, 2, 475-477.
17. Jennett, B., & Bond, M. (1975). Assessment of outcome after severe brain damage. Lancet, 1, 480-484.
18. Ji, Z.S., Miranda, R.D., Newhouse, Y.M., Weisgraber, K.H., Huang, Y., & Mahley, R.W. (2002). Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. Journal of Biological Chemistry, 277, 21821-21828.
19. Jiang, Y., Sun, X., Xia, Y., Tang, W., Cao, Y., & Gu, Y. (2006). Effect of APOE polymorphisms on early responses to traumatic brain injury. Neuroscience Letters, 408, 155-158.
20. Kamboh, M.I., Aston, C.E., & Hamman, R.F. (1995). The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis, 112, 145-159.
21. Kassell, N.F., Sasaki, T., Colohan, A.R., & Nazar, G. (1985). Cerebral vasospasm following aneurysmal subarachnoid hemorrhage [see comment]. Stroke, 16, 562-572.
22. Lanterna, L.A., Rigoldi, M., Tredici, G., Biroli, F., Cesana, C., Gaini, S.M., et al. (2005). APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage. Neurology, 64, 1238-1244.
23. Laskowitz, D.T., Horsburgh, K., & Roses, A.D. (1998). Apolipoprotein E and the CNS response to injury. Journal of Cerebral Blood Flow & Metabolism, 18, 465-471.
24. Leung, C.H., Poon, W.S., Yu, L.M., Wong, G.K., & Ng, H.K. (2002). Apolipoprotein E genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke, 33, 548-552.
25. Lynch, J.R., Morgan, D., Mance, J., Matthew, W.D., & Laskowitz, D.T. (2001). Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. Journal of Neuroimmunology, 114, 107-113.
26. Maas, A.I., Braakman, R., Schouten, H.J., Minderhoud, J.M., & van Zomeren, A.H. (1983). Agreement between physicians on assessment of outcome following severe head injury. Journal of Neurosurgery, 58, 321-325.
27. Mahley, R.W. (1988). Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science, 240, 622-630.
28. Morris, P.G., Wilson, J.T., Dunn, L.T., & Nicoll, J.A. (2004). Apolipoprotein E polymorphism and neuropsychological outcome following subarachnoid haemorrhage. Acta Neurologica Scandinavica, 109, 205-209.
29. Niskakangas, T., Ohman, J., Niemela, M., Ilveskoski, E., Kunnas, T.A., & Karhunen, P.J. (2001). Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: A preliminary study [see comment]. Stroke, 32, 1181-1184.
30. Okuizumi, K., Onodera, O., Tanaka, H., Kobayashi, H., Tsuji, S., Takahashi, H., et al. (1994). ApoE-epsilon 4 and early-onset Alzheimer's. Nature Genetics, 7, 10-11.
31. Roses, A.D. (1994). Apolipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease [see comment]. Journal of Neuropathology and Experimental Neurology, 53, 429-437.
32. Roses, A.D., Strittmatter, W.J., Pericak-Vance, M.A., Corder, E.H., Saunders, A.M., & Schmechel, D.E. (1994). Clinical application of apolipoprotein E genotyping to Alzheimer's disease [see comment]. Lancet, 343, 1564-1565.
33. Ruigrok, Y.M., Slooter, A.J., Bardoel, A., Frijns, C.J., Rinkel, G.J., & Wijmenga, C. (2005). Genes and outcome after aneurysmal subarachnoid haemorrhage. Journal of Neurology, 252, 417-422.
34. Sabo, T., Lomnitski, L., Nyska, A., Beni, S., Maronpot, R.R., Shohami, E., et al. (2000). Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience, 101, 879-884.
35. Sorbi, S., Nacmias, B., Piacentini, S., Repice, A., Latorraca, S., Forleo, P., et al. (1995). ApoE as a prognostic factor for post-traumatic coma [comment]. Nature Medicine, 1, 852.
36. Sturm, J.W., Dewey, H.M., Donnan, G.A., Macdonell, R.A., McNeil, J.J., & Thrift, A.G. (2002). Handicap after stroke: How does it relate to disability, perception of recovery, and stroke subtype? The north North East Melbourne Stroke Incidence Study (NEMESIS). Stroke, 33, 762-768.
37. Sulter, G., Steen, C., & De Keyser, J. (1999). Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke, 30, 1538-1541.
38. Sun, Y., Wu, S., Bu, G., Onifade, M.K., Patel, S.N., LaDu, M.J., et al. (1998). Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. Journal of Neuroscience, 18, 3261-3272.
39. Tang, J., Zhao, J., Zhao, Y., Wang, S., Chen, B., & Zeng, W. (2003). Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. Surgical Neurology, 60, 391-396 ; discussion 396-397.
40. Teasdale, G.M., Nicoll, J.A., Murray, G., & Fiddes, M. (1997). Association of apolipoprotein E polymorphism with outcome after head injury. Lancet, 350, 1069-1071.
41. Tolar, M., Keller, J.N., Chan, S., Mattson, M.P., Marques, M.A., & Crutcher, K.A. (1999). Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. Journal of Neuroscience, 19, 7100-7110.
42. van Duijn, C.M., de Knijff, P., Cruts, M., Wehnert, A., Havekes, L.M., Hofman, A., et al. (1994). Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease [see comment]. Nature Genetics, 7, 74-78.
43. van Swieten, J.C., Koudstaal, P.J., Visser, M.C., Schouten, H.J., & van Gijn, J. (1988). Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 19, 604-607.
44. Voldby, B., & Enevoldsen, E.M. (1982). Intracranial pressure changes following aneurysm rupture. Part 1: Clinical and angiographic correlations. Journal of Neurosurgery, 56, 186-196.
45. Weisgraber, K.H., Roses, A.D., & Strittmatter, W.J. (1994). The role of apolipoprotein E in the nervous system. Current Opinion in Lipidology, 5, 110-116.
46. Wilson, J.T., Pettigrew, L.E., & Teasdale, G.M. (1998). Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use. Journal of Neurotrauma, 15, 573-585.